arrow-left  #marksans-tevapharm

Image not found
     
  • 01 November, 2023 |
  •  
  • 2:21 PM

This acquisition is expected to potentially double the company's existing Indian capacity from 8 billion units per annum

Read More

More News

ALL #marksans-tevapharm
Image not found
  • This acquisition is expected to potentially double the company's existing Indian capacity from 8 billion units per annum
  • |
  • IIFL News Service |
  • 01 November, 2023 |
  • 9:23 PM
Article Image
  • Acetaminophen and Ibuprofen Tablets, 250 mg/125 mg (OTC) are bioequivalent to Advil Dual Action Tablets.
  • |
  • IIFL News Service |
  • 12 July, 2023 |
  • 6:42 PM
Image not found
  • The company via its regulatory filing has informed the exchanges that it has entered into a business agreement to acquire Tevapharm India’s Goa-based bulk pharmaceutical formulations business.
  • India Infoline News Service |
  • 12 October, 2022 |
  • 12:09 PM
Image not found
  • Drug manufacturer Marksans Pharma announced on Tuesday that it has signed a contract with Tevapharm India to purchase the latter's bulk pharmaceutical formulations business in Goa.
  • India Infoline News Service |
  • 12 October, 2022 |
  • 12:09 PM
ad IconAd Image